http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Ivor-Lewis 식도절제술 후 상품형 말초정맥용 영양수액 사용 평가
이선우 ( Sun Woo Lee ),임나리 ( Na Ri Lim ),박효정 ( Hyo Jung Park ),인용원 ( Yong Won In ),서정민 ( Jeong Meen Seo ),이영미 ( Young Mee Lee ) 한국정맥경장영양학회 2015 한국정맥경장영양학회지 Vol.7 No.3
Purpose: Deteriorated nutritional status is common during a hospital stay for esophagectomy in patients with esophageal cancer. Malnutrition in those patients is often marked compared with other gastrointestinal cancer. The purpose of this study is to evaluate the appropriateness of commercial peripheral parenteral nutrition (CPPN) use in patients who underwent Ivor-Lewis esophagectomy (I-L op). Methods: Patients who were provided with CPPN after I-L op were enrolled in this study from January to May 2015. Body weight, height, nutritional status, length of hospital stay, duration of CPPN therapy, and parenteral nutrition (PN) induced complications were assessed, respectively, using electronic medical records. Results: Thirty-nine patients were enrolled. Average age was 65.9 years and 36 patients were male. All patients were provided with the same CPPN. The duration of fasting and CPPN use was 5.8±1.4 days and 7.5±1.8 days, respectively. Calorie supported by CPPN was 22.6±3.5 kcal/kg/day and only 20.5% of patients (n=8) reached the daily target calories. Most frequent PN induced complication was phlebitis which occurred in 8 patients (20.5%). Calcium, magnesium, and transthyretin levels in serum were not monitored during the PN support period. Conclusion: The indications for CPPN were appropriate because the fasting duration in patients with I-L op was 5 to 10 days. Although a large portion of patients could not be supplied daily target calories, their nutrition status was not significantly changed on admission and at discharge. We did not find it necessary to individualize PN support for a short period after an I-L op in patients with esophageal cancer. Further study will be needed to determine why the incidence of phlebitis was dominant.
입원한 암환자 대상으로 정맥영양 시작 시기에 대한 적절성 평가
김남효 ( Nam Hyo Kim ),박효정 ( Hyo Jung Park ),인용원 ( Yong Won In ),이영미 ( Young Mee Lee ) 한국정맥경장영양학회 2017 한국정맥경장영양학회지 Vol.9 No.1
Purpose: Malnutrition is quite prevalent in hospitalized cancer patients, with a 40%∼80% rate. Malnutrition in cancer patients can result in an increase in the number of complications, length of stay, mortality, and morbidity. Therefore, cancer patients with malnutrition must have the appropriate nutritional support to improve the prognosis of cancer. This study evaluated the appropriate time point to start parenteral nutrition (PN) after admission according to the nutrition support guidance in Samsung Medical Center. Methods: This study enrolled patients diagnosed with the Korean standard classification of disease 6 (KCD6) code C00-C97 and discharged from March 1st to 31st, 2016. The following data were collected: patients` age, gender, diagnosis, length of stay, body mass index, nutritional status, and whether to consult nutrition support team (NST). Results: Among a total of 2,944 patients, 381 patients (12.9%) were in a malnourished status upon admission. In the malnourished patients, 139 patients were prescribed PN for a median of 6 days (range, 1∼49) and moderate to severe malnourished patients were started on PN within 2 days after admission. The proportion of patients with a poor nutritional status was lower in the NST group than in the non-NST group (50.0% vs. 66.7%) on the 28th day after admission. Among the nourished patients, 229 patients were prescribed PN. Of them, 183 patients (79.9%) were started on PN within 7 days after admission. Conclusion: In moderate to severe malnourished cancer patients, the initiation of PN on the day after admission is appropriate.
정맥영양요법을 시행한 조혈모세포이식 소아의 재원기간에 영향을 미치는 인자
박효정 ( Hyo Jung Park ),윤정아 ( Jung A Yoon ),김도영 ( Do Young Kim ),허윤정 ( Yoon Jung Huh ),정선영 ( Seon Young Chung ),인용원 ( Yong Won In ),이영미 ( Young Mee Lee ),서정민 ( Jeong Meen Seo ),손기호 ( Kie Ho Sohn ) 한국정맥경장영양학회 2011 한국정맥경장영양학회지 Vol.4 No.1
Purpose: Parenteral nutrition (PN) is a standard supportive care for pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) in Samsung Medical Center. The objective of this study was to identify the factors associated with the length of hospital stay (LOS) in pediatric HSCT patients administrating PN routinely. Methods: This was a retrospective study for 128 pediatric HSCT patients from Aug. 2008 to Dec. 2009. Demographics, nutrition status on the first report in the nutrition support team, calories and nutrients supplied, PN duration, LOS, PN-induced complications, and laboratory data were collected from electronic medical records. Multivariate analyses were conducted to identify factors associated with LOS. Results: The median age of registered patients was 70 months (range 6∼239 months). Twenty-three patients (18.0%) were malnourished moderately to severely when PN was started. Number of autologous HSCT was larger than allogeneic HSCT (87 vs 41). In children undergoing HSCT, LOS was significantly correlated with PN duration (P<0.001) and graft type (P<0.001). Especially, in autologous peripheral blood stem cell transplantation (PBSCT), malnourished patients at the beginning of PN were shown the tendency to increase LOS (P=0.024) and PN duration (P=0.043). Conclusion: In pediatric HSCT patients administrating PN routinely, LOS was associated with a graft type of HSCT and PN duration. Especially for autologous PBSCT patients, the nutrition status at the beginning of PN had the influence on LOS and PN duration. During the peri-HSCT period, careful nutrition monitoring can prevent malnutrition, decrease PN duration, and shorten LOS. (JKSPEN 2011;4(1):1-6)
장승연,최지선,민명숙,인용원,손기호,최경업,김화정,신완균 한국병원약사회 2002 병원약사회지 Vol.19 No.3
To evaluate the usage of total parenteral nutrition(TPN) and to assess the nutritional benefits ad risks of TPN in pediatric hematopoietic stem cell transplantation, 52 pediatric patients who received hematopoietic stem cell transplantation were studied retrospectively. Each patient was monitored until TPN was discontinued or for a maximum of 21days. The mean daily energy intake given intravenously was 80.6±23.3% of basal metabolic rate(BMR) and protein intake was 1.07±0.49g/㎏/d(mean±S.D.). Weight did not present statistically significant variations. Serum albumin levels fell markedly on day 7(3.47±0.34g/dL), but returned to normal on day 14(3.71±0.34g/dL) and then keep up to day 21. Total protein levels were significantly increased on days 7, 14, 21. Blood glucose levels significantly rose from day 14. In metabolic complication, the most frequent abnormalities were hypomagnesemia(65.4%). Blood urea nitrogen(BUN) was below normal on day 0(7.12±3.47㎎/dL) and significantly rose during TPN(11.58±6.87㎎/dL on day 7). Serum creatinine levels significantly decreased on day 14. Transaminases were moderately elevated at the start of TPN, but returned to normal on day 7. Total bilirubin and alkaline phosphatase(ALP) were normal during TPN, with slight fluctuation, always in the normal range. Nutritional support with TPN was effective in maintaining weight and viceral proteins. It is need to close monitoring during TPN in pediatric hematopoietic stem cell transplantation.